Effect of Bilateral Transcutaneous Tibial Nerve Stimulation on Postpartum Constipation
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
This study will be conduct to determine the effect of bilateral transcutaneous tibial nerve stimulation on treating postpartum constipation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2022
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2022
CompletedFirst Posted
Study publicly available on registry
July 13, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedJuly 19, 2022
July 1, 2022
2 months
July 8, 2022
July 15, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
The Bristol Stool Form Scale (BSFS)
It is a formal research tool used to assess stool consistency and intestinal transit rate. It is an ordinal scale used to rate and categorize stool into seven classifications, according to stool consistency It is also useful in evaluating the effectiveness of an intervention for gastrointestinal tract disease and clinical assessment. It helps people to report on stool consistency adequately, thus proving a guide in the diagnosis and treatment of gastrointestinal disorders.It classifies stool into seven categories ranging from hard lumps like nuts stool (type 1) to watery without solid pieces, entirely liquid (type 7). Types 1 and 2 are indicative of constipation, types 3 and 4 are considered normal stool consistency that is easy to defecate, while types 6 and 7 are considered abnormal consistency .
up to 4 weeks
Patient Assessment of Constipation -Symptom Questionnaire (PAC-SYM)
It is frequently used in clinical trials of constipation, it has emerged as an important tool for assessing the severity of patient-reported symptoms of constipation. It consists of 12-item questionnaire that divided into three symptom subscales: abdominal (four items); rectal (three items); and stool (five items). Items are scored on 5-point Likert scales, with scores ranging from 0 to 4 (0 = 'symptom absent', 1 = 'mild', 2 = 'moderate', 3 = 'severe' and 4 = 'very severe'). A mean total score in the range of 0-4 is generated by dividing the total score by the number of questions completed; the lower the total score, the lower the symptom burden. Observational data have shown that PAC-SYM questionnaire has internal consistency, test-retest reliability and concurrent validity, and to be responsive to change over time .
up to 4 weeks
Patient Assessment of constipation quality of life questionnaire (PAC-QOL)
The validated PAC-QOL questionnaire consists of 28 items grouped into 4 subscales ; physical discomfort , psychosocial discomfort, in addition to worries and concerns, and satisfaction, investigating the effects of constipation on the patient's quality of life in the recent 2 weeks. The first three subscale comprise the patient dissatisfaction index (where higher great corresponding to worse quality of life) the satisfaction subscale include 4 items, (where higher great corresponding to improve quality of life .
up to 4 weeks
Rome III criteria: Rome III criteria: Rome III criteria
It will be used to confirm the diagnosis of constipation for all participating women in both groups A and B to ensure that they will meet the eligibility criteria . All women should have at least two of the following criteria: Fewer than three spontaneous bowel movements per week. Straining during at least 25% of defecation attempts. Lumpy or hard stools for at least 25% of defecation attempts. Sensation of anorectal obstruction or blockage for at least 25% of defecation attempts. Sensation of incomplete defecation for at least 25% of defecation attempts. Manual maneuvering required to defecate for at least 25% of defecation attempts (e.g., digital evacuation, support of the pelvic floor). Loose stools are rarely present without the use of laxatives.
up to 4 weeks
Study Arms (2)
bilateral transcutaneous tibial nerve stimulation,exercise and advices
EXPERIMENTAL•They will receive bilateral transcutaneous tibial nerve stimulation three times per week for 4 weeks, in addition to abdominal muscle training and breathing exercise and bowel care advices.
Exercises and advices
EXPERIMENTALThey will perform abdominal muscle training and breathing exercise three times per week, for 4 weeks in addition to bowel care advices.
Interventions
• First group they will receive morning bilateral transcutaneous tibial nerve stimulation, for 30 minutes, three times per week for 4 weeks, in addition to abdominal muscle training and breathing exercise for 15 minutes three times per week, for 4 weeks and bowel care advices.•They will perform abdominal muscle training and breathing exercise, for 15 minutes three times per week, for 4 weeks in addition to bowel care advices. Second group•They will perform abdominal muscle training and breathing exercise, for 15 minutes three times per week, for 4 weeks in addition to bowel care advices.
Eligibility Criteria
You may qualify if:
- Their ages will range from 20 to 35 years old.
- Their body mass index (BMI) will range from 25 to 33 kg/m2.
- All participating women should have at least two criteria of Rome III diagnostic criteria for constipation.
- They should stop laxatives intake during treatment program
You may not qualify if:
- Postpartum women will be excluded if they have:
- History of inflammatory bowel disease, and irritable bowel syndrome.
- Endocrine disease or digestive tract disease.
- History of genital prolapse and anal fissure.
- Congental anorectal malformation, stoma in situ.
- Diabtes mellitus and sever distal venous insuffiency.
- Skin eruption at the site of stimulation.
- Implanted pacemaker or defibrillator.
- Metalic implant in lower limb.
- Recent surgery at the lower limb.
- Peripheral neuropathy and neurological disorders. Psychological distress.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- spechalist of physical therapist at qulin hospital ,kafrelshikh,Egypt .
Study Record Dates
First Submitted
July 8, 2022
First Posted
July 13, 2022
Study Start
August 1, 2022
Primary Completion
October 1, 2022
Study Completion
November 1, 2022
Last Updated
July 19, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will share